Background: Guidelines on the management of aneurysmal subarachnoid hemorrhage (aSAH) recommend euvolemia, whereas hypervolemia may cause harm. We investigated whether high early fluid input is associated with delayed cerebral ischemia (DCI), and if fluid input can be safely decreased using transpulmonary thermodilution (TPT). Methods: We retrospectively included aSAH patients treated at an academic intensive care unit (2007-2011; cohort 1) or managed with TPT (2011-2013; cohort 2). Local guidelines recommended fluid input of 3 L daily. More fluids were administered when daily fluid balance fell below þ500 mL. In cohort 2, fluid input in high-risk patients was guided by cardiac output measured by TPT per a strict protocol. Associations of fluid input and balance with DCI were analyzed with multivariable logistic regression (cohort 1), and changes in hemodynamic indices after institution of TPT assessed with linear mixed models (cohort 2). Results: Cumulative fluid input 0 to 72 hours after admission was associated with DCI in cohort 1 (n=223; odds ratio [OR] 1.19/L; 95% confidence interval 1.07-1.32), whereas cumulative fluid balance was not. In cohort 2 (23 patients), using TPT fluid input could be decreased from 6.0 + 1.0 L before to 3.4 + 0.3 L; P ¼ .012), while preload parameters and consciousness remained stable. Conclusion: High early fluid input was associated with DCI. Invasive hemodynamic monitoring was feasible to reduce fluid input while maintaining preload. These results indicate that fluid loading beyond a normal preload occurs, may increase DCI risk, and can be minimized with TPT.
Introduction
Delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) affects approximately 30% of patients. 1 DCI typically develops between days 4 and 14 after ictus 2 and may progress to cerebral infarction which is associated with poor outcome. 3, 4 Since hypovolemia is associated with DCI, standard management includes maintenance of euvolemia. 5, 6 Nevertheless, ascertainment of euvolemia is problematic in clinical practice but highly relevant for several reasons. Guidelines recommend using meticulous fluid balance monitoring to guide fluid management. However, fluid balance has been shown to be poorly indicative of volume status. 7 In addition, euvolemia as a fluid management goal is subject to interpretation, which is illustrated by highly variable maintenance fluid practices in aSAH across neurocritical care units. [8] [9] [10] In clinical practice, many patients with aSAH receive excessive fluids, with the aim to maintain a positive fluid balance. However, excessive fluid administration may result in more systemic complications (eg, congestive heart failure and pulmonary deterioration). [11] [12] [13] In addition, a recent overview of the current literature suggested that excessive fluids might also be detrimental to neurological outcomes. 10 In contrast, hypervolemic therapy-as part of triple-H therapy-has long been regarded as beneficial rather than potentially harmful in aSAH. 10 Hypervolemia, which may be defined as fluid input exceeding the amount necessary for adequate organ perfusion, may therefore be an ill-recognized cause of harm to the brain. Since fluid management in aSAH still relies importantly on fluid balance, it is clinically relevant to assess whether excessive fluids are beneficial or harmful with regard to neurological clinical course. When "hypervolemia" as defined above is a frequently occurring and undesirable consequence of aiming for positive fluid balances, one may hypothesize that hemodynamic monitoring may help restricting fluid input without compromising adequate cardiac preload and cerebral blood flow.
The main objective of this study was therefore to investigate whether high early fluid input and fluid balances within 72 hours after admission are associated with the occurrence of DCI in patients with aSAH. Our secondary objective was to report on the feasibility of decreasing fluid input guided by cardiac output monitoring with transpulmonary thermodilution (TPT).
Materials and Methods

Study Design and Population
In this report, we describe 2 thematically related but separate studies. A schematic representation of the design and aims of the separate cohorts is shown in Figure 1 . The first study was a retrospective cohort study of consecutively admitted patients with aSAH (cohort 1) to the intensive care unit (ICU) of a university hospital (Erasmus MC, University Medical Center, Rotterdam, the Netherlands) between October 2007 and October 2011, aiming to investigate whether high early fluid input or positive fluid balances were associated with DCI. Because preliminary analyses of cohort 1 showed that high early fluid input was associated with DCI, 14 we instituted a fluid management protocol using fluid responsiveness with TPT using the PiCCO device (Pulsion Medical Systems SE, Feldkirchen, Germany), assuming that a reduction in excessive fluid input while maintaining adequate cardiac preload might be possible. The second study (cohort 2) concerned the first series of patients with aSAH (April 2011-September 2013, admitted to the same unit) managed with this newly instituted TPT protocol (Supplemental File A) and was aimed at retrospectively assessing changes in fluid input and balances in the days before versus after TPT.
The inclusion criteria for cohort 1 were 18 years or older, aSAH, and admission to hospital 48 hours after ictus. The exclusion criteria were heart failure known from medical history, renal insufficiency (creatinine > 150 mmol/L), pregnancy, and death within 48 hours after admission. For cohort 2, the inclusion criteria were similar to the indications for TPT monitoring according to the fluid management protocol and concerned high-risk patients (detailed in Supplemental Files A and B). Briefly, these criteria concerned lower than expected blood pressure or highly negative fluid balance, signs of pulmonary or cardiac dysfunction, or progressive neurological deterioration due to DCI. Patients in both cohorts were identified through a hospital health service code indicating subarachnoid hemorrhage. Institutional medical ethics committee approval for both cohort studies was obtained and informed consent was not necessary, given the observational nature of the studies and anonymization of patient data in accordance with Dutch legislation. Due to the retrospective nature, we did not perform a power analysis and used a sample size of convenience.
Diagnosis and Patient Management
All patients were routinely managed at an ICU. In both cohorts, patients were evaluated with head computed tomography (CT) and CT angiography on admission. When no blood was seen on CT, a lumbar puncture was performed >12 hours after ictus for spectrophotometric analysis of cerebrospinal fluid (CSF). During the inclusion period for cohort 1, coiling procedures were performed by a regional team of interventional neuroradiologists. Stable patients were temporarily transferred to a different hospital for endovascular treatment when an interventional neuroradiologist was not available within 24 hours in the admitting hospital (Erasmus MC). A detailed description of patient management during the ICU admission in the 2 cohorts is given in Supplemental File B.
Data Collection and Outcomes
For both cohorts, data were collected from the ICU patient data management system and electronic patient records. Fluid input included all infusion fluids (including pharmaceuticals, blood products, and intraoperative fluids), tube feeding, and normal diet. Fluid losses included urine output, intraoperative blood loss, gastrointestinal losses, and CSF from intrathecal drains. Insensible loss was not accounted for in the analyses. Fluid balance was calculated by subtracting fluid loss from input.
In cohort 1, fluid input, loss, and balance were collected for the first 3 days after admission (day 1: 0-24 hours, day 2: 24-48 hours, and day 3: 48-72 hours). Admission CT scans were evaluated for Hijdra sum scores. 15 The primary outcome was DCI defined by CT infarction, clinical deterioration, or both without other cause, according to recently proposed consensus criteria. 1, 16 Two authors (L.J.M.V. and M.v.d.J.) assessed the primary outcome. During outcome assessments, the authors were blinded to the daily fluid data. Consensus on the outcomes was obtained by discussion in case of initial disagreement. Glasgow outcome score (GOS) was assessed between 3 and 6 months after admission to the hospital as a secondary outcome. When GOS could not be retrieved from our electronic patient records, we sent a letter to the general practitioner to request the relevant information.
In cohort 2, fluid data and Glasgow coma score (GCS) were collected over a period from 3 days before until 3 days after TPT initiation. The TPT parameters-cardiac index (CI), stroke volume index (SVI), global end-diastolic volume index (GEDVI), and extravascular lung water index (EVLWI)-were collected during the study period and the daily average values recorded. Central venous pressure (CVP) measurements were collected at least from the day before TPT initiation until 3 days after. In this cohort, DCI was assessed as defined in cohort 1 by 1 author (M.E.) who was blinded for other clinical data. In contrast to cohort 1, the primary outcome was the difference in fluid parameters before versus after the start of TPT monitoring.
Statistical Analysis
Data were summarized as number with percentage (categorical), as median with interquartile range (ordinal), and as mean (standard error; continuous). Imputation of missing values in the fluid parameters and Hijdra sum scores in cohort 1 was performed with single imputation with regression based on relevant covariates and outcome (Supplemental File C). Patients with DCI and without DCI in cohort 1 were compared using the Student t test, Mann-Whitney U test, chi-square test, or Fisher exact test. In cohort 1, logistic regression models were created with cumulative fluid input or cumulative fluid balance during the first 24, 48, and 72 hours of ICU admission and previously identified independent predictors of DCI (age, gender, World Federation of Neurosurgical Societies [WFNS] grading score at admission, and Hijdra sum scores on initial CT scan) 17, 18 as covariables. Hijdra scores were dichotomized at their median, and WFNS was dichotomized into good (WFNS, 1-3) and poor (WFNS, 4-5) grades for the analyses. Sensitivity analyses with cerebral infarction on CT due to DCI with or without clinical signs and a secondary analysis with GOS as outcome were performed. Interaction between variables was assessed in each model. To assess whether the relation between fluid input and balance was nonlinear, that is, whether there was a specific cutoff in the effect of fluid on outcome, we did similar analyses with fluid input as covariables dichotomized on a cutoff of 3, 4, and 5 L daily. In cohort 2, fluid and hemodynamic parameters were compared before and after TPT using linear mixed models, with day 3 after initiation of TPT as the reference. The course of patients' GCSs before and after TPT was assessed with Wilcoxon signed rank test. A 2-sided P value of<.05 was considered statistically significant. All statistical analyses were performed using SPSS 20.0.0 (IBM, Chicago, Illinois).
Results
Cohort 1
We included 223 consecutive patients with aSAH, of whom 91 (41%) developed DCI. General characteristics of patients with and without DCI are reported in Table 1 . In total, 119 observations (18%) of fluid input data, 119 observations (18%) of fluid loss data, 8 (3.6%) Hijdra cistern sum scores, and 12 (5.4%) of Hijdra ventricle sum scores were missing and imputed. Mean hemoglobin (Hb) level at days 2 and 3 was lower, and blood pressure at day 1 was higher in patients who developed DCI versus those who did not.
In patients who later developed DCI, fluid input was higher on day 1 (DCI: 4. The sensitivity analysis with DCI infarction as the outcome yielded similar results as those with DCI, but cumulative fluid balances at 0 to 48 and 0 to 72 hours after admission were associated with cerebral infarction due to DCI (0-48 hours: OR 1.15/L, 95% CI 1.00-1.33, and 0-72 hours: OR 1.12/L, 95% CI 1.01-1.25; Supplemental File F). Secondary outcome analysis for GOS showed results similar to the analysis for fluid input and DCI (Supplemental File G).
Cohort 2
We included the first 23 patients with aSAH who had an indication for TPT according to the protocol (Supplemental File A). Table 3 shows some pertinent characteristics on demographics, aneurysm management, and outcomes. Eleven patients (48%) died within 30 days after ICU admission, and this high mortality relates to the inclusion of high-risk patients for TPT, including those with recent signs of DCI. Fluid data from day À3 to day 3 relative to TPT initiation were available for 11, 10, 21, 23, 21, 20, and 20 patients, respectively (eg, only 11/23 patients had been admitted with available fluid data, 3 days before TPT initiation).
Daily fluid parameters and daily GCS are shown in Figure 3 . Compared to day 3 (reference) after TPT initiation (fluid input: 3.4 + 0.3 L), fluid input was higher on day À2 (6.0 + 1.0 L; P ¼ .012) and day À1 (5.3 + 0.9 L; P ¼ .008). Daily fluid loss was lower on day À3 when compared to day 3 (2.7 + 0.5 L vs 3.4 + 0.4 L; P ¼ .049). As a result, daily fluid balance was higher on day À3 (1.8 + 0.6 L; P ¼ .003), day À2 (2.9 + 1.4 L; P < .001), and day À1 (1.4 + 0.4 L; P ¼ .014) when compared to day 3 (0.0 + 0.2 L). Median daily GCS on day À1 was not significantly lower than the median daily GCS on day 3 (GCS of 7 [5.5-7 .5] vs 9 [6] [7] [8] [9] [10] [11] [12] [13] [14] ; P ¼ .18). Most hemodynamic parameters as measured during TPT (CVP, CI, and SVI) remained within the range of normal values in spite of significant reductions in fluid input and balances after start of TPT, except GEDVI and EVLWI which were higher than the normal ranges of 650 to 800 mL/m 2 and 3.0 to 7.0 mL/kg, respectively (Supplemental File H).
Discussion
The main finding of this study in patients with aSAH is that early high daily fluid input was independently associated with DCI and poor outcome. In addition, we showed that fluid loading beyond normal preload occurred in clinical practice and that it was feasible to significantly restrict fluid input while maintaining adequate preload with TPT in selected high-risk patients with aSAH. Taken together, these results corroborate the potential harm from fluid overload in patients with aSAH with regard to DCI and support further study on potential benefit of fluid restriction guided by hemodynamic monitoring.
We found that early high fluid input was associated with DCI. However, our cohort data, and specifically the analyses for fluid input of 3, 4, or 5 L daily, did not indicate a specific cutoff for fluid input beyond which DCI risk was increased. Therefore, firm conclusions about upper limits of fluid input for this cohort are not possible in spite of the robust finding that more fluids associate with DCI risk, indicating that fluid titration in aSAH should still be individualized. In a sensitivity analysis with cerebral infarction on CT as the outcome, positive net fluid balances also showed an association. Furthermore, the hemodynamic data in cohort 2 seem to indicate a state of hypervolemia, since GEDVI was higher than reference values. There are several possible explanations why high fluid input is associated with DCI. 10 First, increased "fluid throughput" may cause fluids to accumulate in the interstitial space when the blood-brain barrier is damaged, which may impede local oxygen diffusion to neurons. [19] [20] [21] Second, hemodilution as a consequence of fluid loading may decrease shear stress in the cerebral arteries, which may be detrimental to the integrity of the blood-brain barrier, 22 and lower Hb levels may contribute to DCI due to decreased oxygen transport capacity of the blood, in line with our findings. Lastly, in cohort 1, as fluid input increased, fluid loss did not increase equally to match the higher fluid input (data not shown). Conversely, in cohort 2, when fluid input decreased, diuresis seemed to increase. Both observations may theoretically be explained by (renal) venous congestion (ie, high CVP). 23 It has been postulated that venous congestion may also impede cerebral venous outflow and lead to intracranial pressure increase. 24 Furthermore, several studies in brain injured critically ill patients have found CVP to be higher in patients with worse neurological outcomes. 11, 13, 25 Similarly, a recent study found that higher CVP was associated with lower brain tissue oxygen saturation and worse outcome in postcardiac arrest patients. 26 We acknowledge that these data do not provide proof and should be considered as hypothesis generating, with regard to the pathophysiologic role of venous congestion in DCI due to excessive fluids.
Our findings substantiate previous findings. Several investigators have described early mean daily fluid input varying from 3.3 to 6.6 L and daily fluid balances varying from À0.6 to þ2.1 L. 7, 25, [27] [28] [29] [30] However, studies investigating the relation between fluid management and DCI are scarce. 25, 29, 31, 32 Two studies investigating the effect of early goal-directed hemodynamic management reported that mean daily fluid input was 2.7 L in the first 3 days with mean fluid balances between À0.5 and 0.5 L when using TPT. 33, 34 Using goal-directed hemodynamic management, less fluid was infused and fewer patients had DCI than in the conventional treatment group in line with our findings. 34 The association of fluid input but not fluid balance with DCI is also in line with previous reports. 28, 33 Some limitations of our study should be considered. Due to the retrospective nature, potential unmeasured confounding factors and retrieval of relevant patient data are an inherent threat to the associations found in cohort 1. Consequently, causality between high fluid input and DCI cannot be proven with this retrospective study. Another limitation is the fact that we did not differentiate between or adjust for crystalloids versus synthetic colloids, since DCI has been associated with the use of synthetic colloids. 29, 35 However, these compounds were administered mainly in case of clinical deteriorations due to DCI as per our protocol at the time of the study period and not typically in the first 3 days when fluid data were collected for this study. Furthermore, we did not adjust fluid parameters for weight. In cohort 2, due to the variable start of the TPT protocol, in relation to clinical admission, missing/unavailable values were unavoidable (eg, when TPT was initiated soon after admission). Finally, our institutional fluid management protocol used in cohort 2 is based on our best clinical practice and the scarce literature available 33, 34 but has not been validated outside our ICU. The patients in cohort 2 are those more likely to develop DCI, so the generalizability of our protocol to lowrisk patients with aSAH is uncertain. Because both cohorts are from a single center and due to the sample size used, the overall generalizability may be limited.
The strengths of our study include a consecutive series of patients managed at an ICU with detailed data on fluid management and prognostic factors as well as assessment of the primary outcome (DCI) according to recently proposed criteria. 1, 16 Second, we imputed missing data, with multiple imputations enhancing the statistical power. Finally, our data are in line with the recent notion that excessive fluid input is an established risk factor for adverse outcome in nonneurological critically ill patients 36 and patients with aSAH in particular. 11, 29, 33, 34, 37 A guideline endorsed by the American Heart Association advised to maintain euvolemia. 5 However, establishing euvolemia is difficult when clear definitions are absent. This is reflected by the fact that mean daily fluid input and fluid balance in cohort 1 exceeded the predefined targets in our institutional protocol. Similarly, the hemodynamic data in cohort 2 suggested patients were hypervolemic when TPT was initiated. A multidisciplinary consensus statement recommended the use of hemodynamic monitoring devices in aSAH, only in hemodynamically unstable patients. 38 A practical approach based on previous literature 10, 39 and our results may be to aim for euvolemia by giving 2.5 to 3.5 L/d in most patients with a fluid balance around 0. Invasive monitoring may then be considered in patients in whom deviations from euvolemia are suspected and considered highly detrimental, or in case of signs of stress cardiomyopathy, neurogenic pulmonary edema, excessive diuresis, or progressive DCI. Of note, with monitoring, the ambiguous term "euvolemia" might best be replaced by "adequate preload."
Conclusion
High early daily fluid input is associated with DCI after aSAH. We showed the feasibility of a protocol using TPT to significantly reduce fluid input and balance without negatively impacting on preload parameters and GCS. Further study seems warranted to determine whether and when hemodynamic monitoring can help establishing both restricted fluid management and improved clinical outcomes.
